Supply Chain Intelligence

Virax Biolabs Group Limited Supply Chain

VRAX supply chain intelligence for Virax Biolabs Group Limited: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

VRAX ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

0Suppliers
7Customers
1Debt Items
20Related Chains

Virax Biolabs Group Limited Suppliers

No suppliers on recordVirax Biolabs Group Limited has not yet been matched to upstream suppliers in our database, or is still being processed.

Virax Biolabs Group Limited Customers

TickerNameConfidenceEvidence
CORPORATIONS CORPORATIONS 90% Our Company has two types of customers: (i) direct end user customers, which may include research organizations, corporations, independent laboratories, large hospital systems and public and private …
DISTRIBUTOR-CUSTOMERS DISTRIBUTOR-CUSTOMERS 90% Our Company has two types of customers: (i) direct end user customers, which may include research organizations, corporations, independent laboratories, large hospital systems and public and private …
INDEPENDENT-LABORATORIES INDEPENDENT-LABORATORIES 90% Our Company has two types of customers: (i) direct end user customers, which may include research organizations, corporations, independent laboratories, large hospital systems and public and private …
LARGE-HOSPITAL-SYSTEMS LARGE-HOSPITAL-SYSTEMS 90% Our Company has two types of customers: (i) direct end user customers, which may include research organizations, corporations, independent laboratories, large hospital systems and public and private …
PUBLIC-AND-PRIVATE-INSTITUTIONS PUBLIC-AND-PRIVATE-INSTITUTIONS 90% Our Company has two types of customers: (i) direct end user customers, which may include research organizations, corporations, independent laboratories, large hospital systems and public and private …
RESEARCH-ORGANIZATIONS RESEARCH-ORGANIZATIONS 90% Our Company has two types of customers: (i) direct end user customers, which may include research organizations, corporations, independent laboratories, large hospital systems and public and private …
NATURAL-SOURCE-GROUP NATURAL-SOURCE-GROUP 62% . This lease was subsequently modified in August 2023 and November 2023 to include additional rooms at BioCity. Lease expense for the year ended March 31, 2024 was GBP 27,521 . The annual rent as of …

Virax Biolabs Group Limited Debt Obligations

InstrumentDescriptionConfidenceEvidence
VRAX-DEBT Debt stack $537,993 90% Market cache reports total debt of $537,993.

Virax Biolabs Group Limited Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Virax Biolabs Group Limited.

Virax Biolabs Group Limited Ownership

HolderNameConfidenceEvidence
VRAX-OWNER-XTX-TOPCO-LTD Xtx Topco Ltd 95% 13F/ownership overlay lists Xtx Topco Ltd; shares held 21,437; ownership 0.49%; value $2,231; as of 2025-12-31.
VRAX-OWNER-NATIONAL-BANK-OF-CANADA-FI National Bank of Canada/FI/ 95% 13F/ownership overlay lists National Bank of Canada/FI/; shares held 6,000; ownership 0.14%; value $624; as of 2025-12-31.
VRAX-OWNER-FARTHER-FINANCE-ADVISORS-LLC Farther Finance Advisors, Llc 95% 13F/ownership overlay lists Farther Finance Advisors, Llc; shares held 21; value $2; as of 2026-03-31.
VRAX-OWNER-OSAIC-HOLDINGS-INC Osaic Holdings Inc. 95% 13F/ownership overlay lists Osaic Holdings Inc.; shares held 20; value $2; as of 2025-12-31.
VRAX-OWNER-NORTHWESTERN-MUTUAL-WEALTH-MANAGEMENT-CO Northwestern Mutual Wealth Management Company 95% 13F/ownership overlay lists Northwestern Mutual Wealth Management Company; shares held 10; value $1; as of 2025-12-31.
VRAX-OWNER-UBS-GROUP-AG UBS Group AG 95% 13F/ownership overlay lists UBS Group AG; shares held 7,492; ownership 0.17%; value $779; as of 2025-12-31.

Virax Biolabs Group Limited Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
IVA Inventiva S.A. 100.00 2
NVS Novartis AG 100.00 2
IDXG Interpace Biosciences, Inc. 100.00 2
ITGR Integer Holdings Corporation 100.00 2
IINN Inspira Technologies Oxy B.H.N. Ltd. 100.00 2
NBP NovaBridge Biosciences 100.00 2
AORT Artivion, Inc. 100.00 2
EXAS Exact Sciences Corp 100.00 2
GIFOF Grifols, S.A. 100.00 2
GIFLF Grifols, S.A. 100.00 2
VTAK Catheter Precision, Inc. 100.00 2
GCTK GlucoTrack, Inc. 100.00 2
GRAL GRAIL, Inc. 100.00 2
GRFS Grifols, S.A. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
FLGT Fulgent Genetics, Inc. 100.00 2
ALVO Alvotech 100.00 2
GIKLY Grifols, S.A. 100.00 2
PSNL Personalis, Inc. 100.00 2
STQN Strategic Acquisitions, Inc. 100.00 2
View VRAX supply chain intel →

Explore the full interactive supply chain map for Virax Biolabs Group Limited.

Open VRAX supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map